Long-term results of ablation with antireflux surgery for Barrett's esophagus: A clinical and molecular biologic study

Surgical Endoscopy

Volumn 26, Issue 7, 2012, Pages 1892-1897

  Kauttu, Tuuli ^a   Räsänen, Jari ^a   Krogerus, Leena ^a   Sihvo, Eero ^a   Puolakkainen, Pauli ^a   Salo, Jarmo A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Ablation; Antireflux surgery; Barrett's esophagus; Immunohistochemistry; Long term follow up; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; GLUTATHIONE; MYELOPEROXIDASE; PROTEIN P53; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR CDX2;

ADOLESCENT; ANTIREFLUX OPERATION; ARTICLE; BARRETT ESOPHAGUS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; INTESTINE METAPLASIA; LASER SURGERY; MALE; NEODYMIUM LASER; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SQUAMOUS EPITHELIUM;

EID: 84864060477     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-011-2121-3     Document Type: Article

References (27)

1. Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W (2001) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. J Am Med Assoc 285:2331-2338
2. Kauttu TM, Rantanen TK, Sihvo EI, Rasanen JV, Puolakkainen P, Salo JA (2011) Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis. Eur J Cardiothorac Surg 40:1450-1454
3. Parrilla P, Martinez de Haro LF, Ortiz A, Munitiz V, Molina J, Bermejo J, Canteras M (2003) Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann Surg 237:291-298
4. Bowers SP, Mattar SG, Waring PJ, Galloway K, Nasir A, Pascal R, Hunter JG (2003) KTP laser ablation of Barrett's esophagus after antireflux surgery results in long-term loss of intestinal metaplasia: potassium-titanyl-phosphate. Surg Endosc 17:49-54
5. Ferraris R, Fracchia M, Foti M, Sidoli L, Taraglio S, Vigano L, Giaccone C, Rebecchi F, Meineri G, Senore C, Pera A (2007) Barrett's oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence. Aliment Pharmacol Ther 25:835-840
6. Garewal H, Ramsey L, Sharma P, Kraus K, Sampliner R, Fass R (1999) Biomarker studies in reversed Barrett's esophagus. Am J Gastroenterol 94:2829-2833
7. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals, and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40
8. Olyaee M, Sontag S, Salman W, Schnell T, Mobarhan S, Eiznhamer D, Keshavarzian A (1995) Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus. Gut 37:168-173
9. Rasanen JV, Sihvo EI, Ahotupa MO, Farkkila MA, Salo JA (2007) The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours. Eur J Surg Oncol 33:1164-1168
10. Sihvo EI, Salminen JT, Rantanen TK, Ramo OJ, Ahotupa M, Farkkila M, Auvinen MI, Salo JA (2002) Oxidative stress has a role in malignant transformation in Barrett's oesophagus. Int J Cancer 102:551-555
11. Rantanen TK, Rasanen JV, Sihvo EI, Ahotupa MO, Farkkila MA, Salo JA (2006) The impact of antireflux surgery on oxidative stress of esophageal mucosa caused by gastroesophageal reflux disease: 4-yr follow-up study. Am J Gastroenterol 101:222-228
12. Dvorak K, Payne CM, Chavarria M, Ramsey L, Dvorakova B, Bernstein H, Holubec H, Sampliner RE, Guy N, Condon A, Bernstein C, Green SB, Prasad A, Garewal HS (2007) Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut 56:763-771
13. Prasad GA, Bansal A, Sharma P, Wang KK (2010) Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol 105:1490-1502
14. Moons LM, Bax DA, Kuipers EJ, Van Dekken H, Haringsma J, Van Vliet AH, Siersema PD, Kusters JG (2004) The homeodomain protein CDX2 is an early marker of Barrett's oesophagus. J Clin Pathol 57:1063-1068
15. Salo JA, Salminen JT, Kiviluoto TA, Nemlander AT, Ramo OJ, Farkkila MA, Kivilaakso EO, Mattila SP (1998) Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg 227:40-44
16. Laihia JK, Jansen CT, Ahotupa M (1993) Lucigenin and linoleate enhanced chemiluminescent assay for superoxide dismutase activity. Free Radic Biol Med 14:457-461
17. Saville B (1958) A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 83:670-672
18. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T (1983) Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 132:345-352
19. Rantanen TK, Salminen JT, Makinen JE, Sipponen PI, Kiviluoto TA, Salo JA (2001) Clinical significance of esophageal histologic findings after antireflux surgery. Arch Surg 136:733-736
20. Bright T, Watson DI, Tam W, Game PA, Astill D, Ackroyd R, Wijnhoven BP, Devitt PG, Schoeman MN (2007) Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results. Ann Surg 246:1016-1020
21. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, Jobe BA, Eisen GM, Fennerty MB, Hunter JG, Fleischer DE, Sharma VK, Hawes RH, Hoffman BJ, Rothstein RI, Gordon SR, Mashimo H, Chang KJ, Muthusamy VR, Edmundowicz SA, Spechler SJ, Siddiqui AA, Souza RF, Infantolino A, Falk GW, Kimmey MB, Madanick RD, Chak A, Lightdale CJ (2009) Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 360:2277-2288
22. Ortiz A, Martinez de Haro LF, Parrilla P, Morales G, Molina J, Bermejo J, Liron R, Aguilar J (1996) Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study. Br J Surg 83:274-278
23. Rossi M, Barreca M, de Bortoli N, Renzi C, Santi S, Gennai A, Bellini M, Costa F, Conio M, Marchi S (2006) Efficacy of Nissen fundoplication versus medical therapy in the regression of lowgrade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg 243:58-63
24. Jimenez P, Piazuelo E, Sanchez MT, Ortego J, Soteras F, Lanas A (2005) Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus. World J Gastroenterol 11:2697-2703
25. Huo X, Zhang HY, Zhang XI, Lynch JP, Strauch ED, Wang JY, Melton SD, Genta RM, Wang DH, Spechler SJ, Souza RF (2010) Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus. Gastroenterology 139:194-203
26. Lopes CV, Pereira-Lima J, Hartmann AA (2005) p53 Immunohistochemical expression in Barrett's esophagus before and after endoscopic ablation by argon plasma coagulation. Scand J Gastroenterol 40:259-263
27. Pouw RE, Gondrie JJ, Rygiel AM, Sondermeijer CM, ten Kate FJ, Odze RD, Vieth M, Krishnadath KK, Bergman JJ (2009) Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia. Am J Gastroenterol 104:1366-1373